Sanara MedTech Reports Q4 Preliminary Revenue Rose; Elizabeth Taylor Named CFO

MT Newswires Live01-21

Sanara MedTech (SMTI) reported Q4 preliminary revenue late Tuesday of $25.7 million to $26.2 million, up 45% to 48% from a year earlier.

Two analysts polled by FactSet expect $22.8 million.

The company said it had cash of $15.9 million as of Dec. 31, compared with $16.3 million as of Sept. 30.

Sanara MedTech appointed Elizabeth Taylor as chief financial officer, succeeding Michael McNeil, who was named chief accounting officer and chief administrative officer.

The appointments were effective Jan. 15, the company said Tuesday in a statement.

Taylor most recently served as CFO of Imbed Biosciences.

Sanara MedTech shares rose 9.7% in recent after-hours activity.

Price: 37.28, Change: +3.28, Percent Change: +9.65

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment